Latest / Stock Movers / JM Smucker Rises, SailPoint Slides, Nuvalent Jumps on GSK Deal
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some stocks on the move today.
- 0:18Speaker 3: I'm Emily Graffeo and for Tim Stenovik with Carol Masser,
- 0:21Speaker 3: and we're joined by Bloomberg Television Markets correspondent Nora Melnda.
- 0:26Speaker 4: Nora.
- 0:26Speaker 3: Let's start with one of the best performers in the
- 0:28Speaker 3: S and P five hundred today, JM Smucker on a.
- 0:32Speaker 4: Tear ticker SJM, heading forward its best day since March
- 0:36Speaker 4: twenty twenty, back in those pandemic days. This is after
- 0:39Speaker 4: reporting a better than expected earnings report, but also announcing
- 0:42Speaker 4: plans to lower coffee prices next year. Now, higher prices
- 0:46Speaker 4: for coffee and sweet big goods have actually helped drive
- 0:50Speaker 4: sales for this company in the latest quarter. And taking
- 0:52Speaker 4: a look at how this company has been performing a
- 0:54Speaker 4: year today, the stock is up about fourteen percent so
- 0:57Speaker 4: far in twenty twenty six.
- 0:59Speaker 1: All right, so interesting to see, but again it's not
- 1:01Speaker 1: a name that we throw out there. A lot as
- 1:04Speaker 1: you mind, you said, like a lot of the consumer
- 1:06Speaker 1: staples right.
- 1:07Speaker 3: A lot of these stapers peanut butter coffee. I mean,
- 1:10Speaker 3: people need this milk bone.
- 1:13Speaker 4: I immediately think of Shelley for some reason when I
- 1:15Speaker 4: think of Smuckers, but they have so many wide ranging products.
- 1:18Speaker 3: They do.
- 1:19Speaker 1: They have a lot of products. But you're right, there
- 1:20Speaker 1: are known for their chill. Take us to a ticker
- 1:24Speaker 1: that I.
- 1:25Speaker 4: Love, sale Sale point. So seeing the stock seeing its
- 1:28Speaker 4: worst day since March, down as much as fifteen percent,
- 1:32Speaker 4: now this is even after the company beat on revenue estimates.
- 1:36Speaker 4: It also raises full year outlook. But the stock is
- 1:38Speaker 4: still down more than twenty percent, down about twenty four
- 1:42Speaker 4: percent twenty three, twenty four percent this year after a
- 1:45Speaker 4: powerful rebound that we did see from its April lows.
- 1:48Speaker 4: So down double digits on the day. People kind of
- 1:51Speaker 4: taking this report in a harsh fashion, really beating down
- 1:54Speaker 4: on the company. But to point out again beating on
- 1:57Speaker 4: revenue estimates and raising full year outlook.
- 1:59Speaker 1: All right, and this is about an eight point eight
- 2:01Speaker 1: billion dollar market cap company that is, as you said,
- 2:04Speaker 1: you know, under pressure, but also down about twenty three
- 2:06Speaker 1: percent year today in about almost eighteen percent of the
- 2:09Speaker 1: float short, so a lot of negative secting out there and.
- 2:12Speaker 3: A software stock too, right, it is a.
- 2:13Speaker 1: Software name, infrastructure software.
- 2:15Speaker 4: Absolutely, yeah, all right, so your name is getting hammered.
- 2:18Speaker 1: Yeah, okay, so it's interesting to see that one. Hey,
- 2:20Speaker 1: take us to Neuvalent and what's going on there.
- 2:23Speaker 4: So let's talk a little bit of M and A
- 2:25Speaker 4: Neuvalent take her in UVL. So GSK is buying this
- 2:29Speaker 4: biotech company for roughly ten point six billion dollars. Now,
- 2:34Speaker 4: this is basically forty percent premium, and this is and
- 2:37Speaker 4: hopes to expand its lung cancer portfolio. So, as you'd
- 2:40Speaker 4: imagine when we see these M and A transactions happening,
- 2:43Speaker 4: Nuvalent heating its highest level on record today. But the
- 2:47Speaker 4: deal also release strengthens GSK's drug line pipeline ahead of
- 2:52Speaker 4: some of the upcoming patent expirations for some of its
- 2:55Speaker 4: top selling medicines. When you're looking for news, today's a
- 2:58Speaker 4: busy day, but even on a quiet one, I feel
- 2:59Speaker 4: like you look to biotech, any of those healthcare names,
- 3:02Speaker 4: and you're going to find something going on. So there's
- 3:04Speaker 4: some M and A for today.
- 3:05Speaker 1: Yeah, I mean quite a premium right for that name.
- 3:08Speaker 1: But you do think about all of these big you
- 3:10Speaker 1: know drug companies and they need to be thinking about
- 3:12Speaker 1: their their pipeline where the growth comes in the future,
- 3:15Speaker 1: and often they do that through acquisition.
- 3:20Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:24Speaker 2: us throughout the day for the latest roundup of companies
- 3:27Speaker 2: making news on Wall Street and for the latest market
- 3:30Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:34Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:38Speaker 2: the Bloomberg Business App.